Healthcare is a human right.


All Americans deserve the right to high-quality, inclusive, and affordable healthcare, regardless of age.

Lack of access translates to delays in care, higher costs to the patient and healthcare system as a whole and increased consumer debt, forcing young people into untenable financial circumstances.

The passage of the Affordable Care Act in 2010 marked significant improvements for access to care by young adults. Individuals up to age 26 could remain covered on parents’ healthcare plans, and many more young people were able to purchase insurance independently through their state exchange plans with the assistance of premium support.

These changes alone extended access to lower cost, quality care to over 1.2 million young Americans who were previously uninsured. While these are improvements, there is still much work to be done to ensure all young people have access to quality, affordable care.

Tell Congress: Lower drug prices now via Build Back Better.

Tell your members of Congress to include provisions that allow Medicare to negotiate drug prices in the final Build Back Better plan.

Where We Stand

AYA supports legislation that:

  • Preserves and protects young people’s ability to access needed healthcare.
  • Lowers the costs of needed prescriptions, medical visits, and premiums.
  • Ensures high-quality care that is inclusive of all young adults’ needs, regardless of gender, nationality, race, religion, national origin, or sexual orientation.

Legislation AYA Supports

Medicare For All Act of 2021

The most progressive healthcare bill to date, the Medicare for All Bill, introduced by Rep. Jayapal (D-WA) and Senator Bernie Sanders (I-VT), would establish a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals upon birth or residency in the United States; and (3) cover items and services that are medically necessary or appropriate to maintain health or to diagnose, treat, or rehabilitate a health condition, including hospital services, prescription drugs, mental health and substance abuse treatment, dental and vision services, and long-term care. Additionally, the legislation would prohibit cost-sharing (e.g., deductibles, coinsurance, and copayments) and other charges for covered services. Further, private health insurers and employers may only offer coverage that is supplemental to, and not duplicative of, benefits provided under the program. Lastly, the bill would establish a series of implementing provisions relating to (1) health care provider participation; (2) HHS administration; and (3) payments and costs, including the requirement that HHS negotiate prices for prescription drugs.

Fair Accountability and Innovative Research (FAIR) Drug Pricing Act

This bipartisan legislation introduced by Sens. Tammy Baldwin (D-WI), Mike Braun (R-IN), Tina Smith (D-MN) and Lisa Murkowski (R-AK) provides needed price transparency on planned drug price increases by drug manufacturers. Increasing transparency provides incredibly important information to patients and taxpayers, and may help lower the likelihood of relentless price increases for needed therapies. The FAIR Drug Pricing Act requires manufacturers to notify the US Department of Health and Human Services (HHS) and submit transparency and justification report 30 days before they increase the price of certain drugs that cost at least $100 by more than 10 percent in one year or 25 percent over three years. For each price increase, manufacturers will be required to provide a justification as well.

Lower Drug Costs Now Act (H.R. 3)

H.R. 3, the Lower Drug Costs Now Act, reintroduced in 2021 by Reps. Pallone, Neal, and Scott, is one of the most comprehensive bills currently before Congress that seeks to lower the rising costs of prescription drugs. The bill gives Medicare the power to negotiate directly with the drug companies, makes those lower negotiated drug prices available to all Americans with private insurance, limits the maximum price that a company charge to an average price charged in similar countries, and includes a number of important drug price transparency provisions that will help bring down the costs of drugs.